Eloralintide And Tirzepatide
A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity
Eli Lilly · Phase 1 · Completed · Enrollment 188
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Eloralintide and Tirzepatide-Cohorts A-D | n/r | n/r | n/r | n/r | n/r |
| Eloralintide-Cohorts E and F | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.